PLx Pharma Winddown Corp.
PLXPQ
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 386.00K | 483.00K | 2.08M | 1.59M | 6.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 386.00K | 483.00K | 2.08M | 1.59M | 6.62M |
| Cost of Revenue | 1.46M | 820.00K | 1.17M | 892.30K | 3.91M |
| Gross Profit | -1.07M | -337.00K | 914.00K | 699.60K | 2.70M |
| SG&A Expenses | 9.14M | 13.65M | 18.46M | 20.86M | 11.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.23M | 15.02M | 20.28M | 22.44M | 16.48M |
| Operating Income | -10.84M | -14.54M | -18.20M | -20.85M | -9.86M |
| Income Before Tax | -8.50M | -11.86M | -10.79M | 3.56M | -21.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.50M | -11.86M | -10.79M | 3.56M | -21.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.50M | -11.86M | -10.79M | 3.56M | -21.64M |
| EBIT | -10.84M | -14.54M | -18.20M | -20.85M | -9.86M |
| EBITDA | -10.81M | -14.51M | -18.17M | -20.82M | -9.83M |
| EPS Basic | -0.30 | -0.43 | -0.39 | 0.13 | -0.80 |
| Normalized Basic EPS | -0.19 | -0.27 | -0.24 | 0.08 | -0.50 |
| EPS Diluted | -0.30 | -0.43 | -0.39 | 0.13 | -0.80 |
| Normalized Diluted EPS | -0.19 | -0.27 | -0.24 | 0.08 | -0.50 |
| Average Basic Shares Outstanding | 28.60M | 27.69M | 27.54M | 27.53M | 26.91M |
| Average Diluted Shares Outstanding | 28.60M | 27.69M | 27.54M | 27.53M | 26.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |